These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16248840)

  • 41. Alteration of fexofenadine disposition in the rat isolated perfused liver following injection of bacterial lipopolysaccharide.
    Tong Y; Zhang R; Ngo SN; Davey AK
    Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):685-9. PubMed ID: 16895540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolism of flupyrazofos in the isolated perfused rat liver.
    Jeong CK; Lee HY; Kim SB; Choi SJ; Kim JH; Kim K; Han SS; Lee HS
    Pest Manag Sci; 2001 May; 57(5):427-31. PubMed ID: 11374159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of albumin on the disposition of morphine and morphine-3-glucuronide in the rat isolated perfused liver.
    O'Brien JA; Evans AM; Nation RL
    Clin Exp Pharmacol Physiol; 1997 Feb; 24(2):143-8. PubMed ID: 9075586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolism and biliary excretion of trimetrexate by the isolated perfused rat liver.
    Webster LK; Tong WP; McCormack JJ
    Cancer Lett; 1985 Oct; 29(1):65-71. PubMed ID: 2933139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolism of roxithromycin in the isolated perfused rat liver.
    Jarukamjorn K; Thalhammer T; Gollackner B; Pittenauer E; Jäger W
    J Pharm Pharmacol; 1998 May; 50(5):515-9. PubMed ID: 9643445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of tauroursodeoxycholic and taurodeoxycholic acids on hepatic metabolism and biliary secretion of phosphatidylcholine in the isolated rat liver.
    Alvaro D; Angelico M; Cantafora A; Di Biase A; Gaeta GB; Ginanni Corradini S; Tripodi MF; Attili AF; Utili R
    Biochim Biophys Acta; 1986 Sep; 878(2):216-24. PubMed ID: 3756193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dose-dependent inhibition of transporter-mediated hepatic uptake and biliary excretion of methotrexate by cyclosporine A in an isolated perfused rat liver model.
    Parasrampuria R; Mehvar R
    J Pharm Sci; 2010 Dec; 99(12):5060-9. PubMed ID: 20821379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uptake and disposition of chlorinated biphenyls by isolated perfused rat liver.
    Mehendale HM
    Drug Metab Dispos; 1976; 4(2):124-32. PubMed ID: 5256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disposition of the antimalarial, mefloquine, in the isolated perfused rat liver.
    Coleman MD; Fleckenstein L; Shipley LA; Heiffer MH
    Biochem Pharmacol; 1988 Jan; 37(2):235-9. PubMed ID: 3257698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolism of the anticancer drug flavopiridol, a new inhibitor of cyclin dependent kinases, in rat liver.
    Jäger W; Zembsch B; Wolschann P; Pittenauer E; Senderowicz AM; Sausville EA; Sedlacek HH; Graf J; Thalhammer T
    Life Sci; 1998; 62(20):1861-73. PubMed ID: 9600328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic disposition and metabolite kinetics of a homologous series of diflunisal esters.
    Hung DY; Mellick GD; Anissimov YG; Weiss M; Roberts MS
    J Pharm Sci; 1998 Aug; 87(8):943-51. PubMed ID: 9687338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic kinetics of SCP-1 (N-[alpha-(1,2-benzisothiazol-3(2H)-ona-1, 1-dioxide-2-yl)-acetyl]-p-aminophenol) compared with acetaminophen in isolated rat liver.
    González-Martin G; Lyndon C; Sunkel C
    Eur J Pharm Biopharm; 1998 Nov; 46(3):293-7. PubMed ID: 9885301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms of hepatic methylmercury uptake.
    Ballatori N; Truong AT
    J Toxicol Environ Health; 1995 Nov; 46(3):343-53. PubMed ID: 7473862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolism of UCN-01 in isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides.
    Hagenauer B; Maier-Salamon A; Thalhammer T; Zöllner P; Senderowicz A; Jäger W
    Oncol Rep; 2004 May; 11(5):1069-75. PubMed ID: 15069549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatic clearance and retention of aluminium: studies in the isolated perfused rat liver.
    Wilhelm M; Jaeger DE; Schüll-Cablitz H; Hafner D; Idel H
    Toxicol Lett; 1996 Dec; 89(3):257-63. PubMed ID: 9001595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig.
    Milne RW; Jensen RH; Larsen C; Evans AM; Nation RL
    Pharm Res; 1997 Aug; 14(8):1014-8. PubMed ID: 9279882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic glutathione concentrations and the release of pyrrolic metabolites of the pyrrolizidine alkaloid, monocrotaline, from the isolated perfused liver.
    Nigra L; Huxtable RJ
    Toxicon; 1992 Oct; 30(10):1195-202. PubMed ID: 1440625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of a loading wash-out method for investigating the hepatocellular efflux of a hepatically-generated metabolite, morphine-3-glucuronide.
    Evans AM; O'Brien J; Nation RL
    J Pharm Pharmacol; 1999 Nov; 51(11):1289-97. PubMed ID: 10632087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic disposition of the cytochrome P450 2E1 marker chlorzoxazone and its hydroxylated metabolite in isolated perfused rat livers.
    Mehvar R; Vuppugalla R
    J Pharm Sci; 2006 Jul; 95(7):1414-24. PubMed ID: 16724323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolism and clearance of T-2 mycotoxin in perfused rat livers.
    Pace JG
    Fundam Appl Toxicol; 1986 Oct; 7(3):424-33. PubMed ID: 3781132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.